Compare Nuwellis Inc (NUWE) vs Taskus Inc (TASK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Taskus Inc — how do they compare? Nuwellis Inc trades at $0.79 (market cap $2.54M), while Taskus Inc trades at $7.59 (market cap $693.61M). The key difference: Taskus Inc is far larger — about 273.1× Nuwellis Inc's market cap, and Taskus Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | TASK | |
|---|---|---|
Market Cap | $2.54M | $693.61M |
Sector | Technology | Technology |
52-Week High | $164.50 | $18.03 |
52-Week Low | $0.73 | $4.57 |
Enterprise Value | -$1.17M | $1.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.
While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.
TaskUs (TASK) trades at $7.65, down 3.29% on the day, with mixed technical signals showing a neutral overall trend. Fundamentally, the company demonstrates strong profitability with 36.08% gross margins and 8.75% net income margin, while trading at attractive valuation multiples including a P/E of 6.59 and P/S of 0.58. Recent Q2 2026 earnings beat expectations with $0.33 EPS versus $0.28 expected, driven by 5% revenue growth to $308.9 million.
The stock presents value opportunity with analyst consensus target of $8.00 representing 4.6% upside, supported by 55% buy ratings. Key risks include client concentration and competitive pressures in the AI services space, while positive catalysts include continued AI adoption and new CFO leadership driving operational efficiency.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Taskus Inc
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →
